Tag: Novartis

All

FDA Approves Novartis’ New IL-17A-Blocking Psoriasis Drug Cosentyx

Novartis' Cosentyx is the first approved human monoclonal antibody that selectively binds to interleukin IL-17A.

Odomzo Gets FDA Nod for Locally Advanced BCC
Global Eczema Treatment Market To Double in Value by 2024

All

Sorry, No Posts Found

All

AAAMS Launches Mentorship Program to Support Early-Career Aesthetic Injectors

Located in Beverly Hills, the program provides certified aesthetic medicine practitioners with hands-on experience treating clients under expert supervision.

AI Tool Enables Automated Evaluation of Facial Palsy
Do Viral Acne Hacks Work? A Dermatologist Weighs In
Inside a War Zone: Dr Manoj Abraham on Leading FACE TO FACE’s Fourth Surgical Mission to Ukraine

Tag: Novartis

All

FDA Approves Novartis’ New IL-17A-Blocking Psoriasis Drug Cosentyx

Odomzo Gets FDA Nod for Locally Advanced BCC

Global Eczema Treatment Market To Double in Value by 2024

All

Sorry, No Posts Found

All

AAAMS Launches Mentorship Program to Support Early-Career Aesthetic Injectors

AI Tool Enables Automated Evaluation of Facial Palsy

Do Viral Acne Hacks Work? A Dermatologist Weighs In

Inside a War Zone: Dr Manoj Abraham on Leading FACE TO FACE’s Fourth Surgical Mission to Ukraine

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links